Current Opinion in Infectious Diseases

Papers
(The TQCC of Current Opinion in Infectious Diseases is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Update on group A streptococcal vaccine development59
Aspergillus fumigatus and pan-azole resistance: who should be concerned?57
Artemisinin and multidrug-resistant Plasmodium falciparum – a threat for malaria control and elimination55
Skin manifestations of Pseudomonas aeruginosa infections49
Current choices of antibiotic treatment for Pseudomonas aeruginosa infections48
Central nervous system infections produced by varicella zoster virus46
COVID-19 in children: current evidence and key questions45
Sapovirus: an emerging cause of childhood diarrhea42
Pediatric acute gastroenteritis associated with adenovirus 40/41 in low-income and middle-income countries42
Giardiasis treatment: an update with a focus on refractory disease35
Mucosal immunity to severe acute respiratory syndrome coronavirus 2 infection34
Tuberculous meningitis: where to from here?30
Updates on defining and detecting diarrheagenic Escherichia coli pathotypes29
Continuous versus intermittent infusion of antibiotics in Gram-negative multidrug-resistant infections28
Antimicrobial-resistant bacteria in international travelers26
Long COVID in children and adolescents23
Parental vaccine hesitancy: scope, causes, and potential responses23
Techniques in bacterial strain typing: past, present, and future21
Risks of metabolic syndrome and diabetes with integrase inhibitor-based therapy20
Infections after anti-CD19 chimeric antigen receptor T-cell therapy for hematologic malignancies: timeline, prevention, and uncertainties20
New drugs for methicillin-resistant Staphylococcus aureus skin and soft tissue infections19
Zoonoses and global epidemics19
Biotypes of HIV-associated neurocognitive disorders based on viral and immune pathogenesis19
Choosing antibiotic therapy for severe community-acquired pneumonia18
Methicillin-resistant Staphylococcus aureus lung infection in coronavirus disease 2019: how common?18
Epstein–Barr virus posttransplant lymphoproliferative disorder: update on management and outcomes18
Potential and demonstrated impacts of the COVID-19 pandemic on sexually transmissible infections18
Scrub typhus: a reemerging infection18
MDRO transmission in acute hospitals during the COVID-19 pandemic17
Emerging treatment options for cryptosporidiosis17
Prolonged infusion of beta-lactam antibiotics for Gram-negative infections: rationale and evidence base16
Policy and planning for large epidemics and pandemics – challenges and lessons learned from COVID-1916
Final frontiers of the polio eradication endgame16
Gram-negative endocarditis: disease presentation, diagnosis and treatment16
Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside16
Nebulized antibiotics for ventilator-associated pneumonia: methodological framework for future multicenter randomized controlled trials15
Subarachnoid neurocysticercosis: emerging concepts and treatment15
Coronavirus disease 2019 vaccination in transplant recipients15
New testing guidelines for community-acquired pneumonia14
Predictors of multidrug resistant Pseudomonas aeruginosa involvement in bloodstream infections14
Unresolved issues in the identification and treatment of carbapenem-resistant Gram-negative organisms14
Update on cytomegalovirus in transplant recipients: new agents, prophylaxis, and cell-mediated immunity13
Melioidosis and Burkholderia pseudomallei: progress in epidemiology, diagnosis, treatment and vaccination13
COVID-19 transmission and the safety of air travel during the pandemic: a scoping review13
Drivers of melioidosis endemicity: epidemiological transition, zoonosis, and climate change13
Typhoid fever control in the 21st century: where are we now?13
Bacteriophage therapy as a treatment option for transplant infections12
Nonviral sexually transmitted infections in pregnancy: current controversies and new challenges12
Clinical and economic impact of bacterial resistance: an approach to infection control and antimicrobial stewardship solutions12
Skin manifestations in patients with coronavirus disease 201912
Immunocompromised host section: Adoptive T-cell therapy for dsDNA viruses in allogeneic hematopoietic cell transplant recipients12
Long-acting injectable HIV therapies: the next frontier11
Asymptomatic bacteriuria and urinary tract infections in kidney transplant recipients11
Hospital water as the source of healthcare-associated infection and antimicrobial-resistant organisms11
What will it take to meet UNAIDS targets for preexposure prophylaxis users?11
Viral meningitis and encephalitis: an update11
Prevention of SARS-CoV-2 and respiratory viral infections in healthcare settings: current and emerging concepts11
Choice and duration of antifungal prophylaxis and treatment in high-risk haematology patients11
Staphylococcus aureus infections in children11
Neurologic aspects of coronavirus disease of 2019 infection11
Dengue vaccine development: challenges and prospects11
Mind the gaps: challenges in the clinical management of invasive candidiasis in critically ill patients11
Management dilemmas in Nocardia brain infection10
Duration of antibiotic therapy in central venous catheter-related bloodstream infection due to Gram-negative bacilli10
Respiratory metagenomics: route to routine service10
Clinical application of non-coding RNAs in sepsis10
What is new with hand hygiene?10
Mycobacterial skin infection10
Infections associated with the new ‘nibs and mabs’ and cellular therapies10
Diagnosis of invasive fungal disease in coronavirus disease 2019: approaches and pitfalls10
Antibiotic treatment of common infections: more evidence to support shorter durations10
Respiratory syncytial virus infection in the modern era10
Frailty in people living with HIV: an update10
Echocardiography and FDG-PET/CT scan in Gram-negative bacteremia and cardiovascular infections9
Immunotherapeutic approaches to HIV cure and remission9
Emergence of a novel urogenital-tropic Neisseria meningitidis9
Treatment of extended-spectrum β-lactamases infections: what is the current role of new β-lactams/β-lactamase inhibitors?9
Neuroradiology of infectious diseases9
Hyperammonemia syndrome in immunosuppressed individuals9
New trends in congenital syphilis: epidemiology, testing in pregnancy, and management9
Siderophores: a potential role as a diagnostic for invasive fungal disease9
Giardia and growth impairment in children in high-prevalence settings: consequence or co-incidence?9
Effects of HIV voluntary medical male circumcision programs on sexually transmitted infections9
Role of new antibiotics in extended-spectrum β-lactamase-, AmpC- infections9
The role of new antimicrobials for Gram-negative infections in daily clinical practice9
Dose optimisation of antibiotics used for meningitis9
Brain calcification because of neurocysticercosis: a vast field to be explored9
Invasive aspergillosis in coronavirus disease 2019: a practical approach for clinicians9
0.035336971282959